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Context: Exercise training enhances insulin sensitivity. Changes in retinol-binding protein-4 (RBP4)
and adiponectin levels are linked to insulin resistance.
Objective: We tested whether the insulin-sensitizing effect of exercise is associated with age-
related changes in circulating RBP4 and adiponectin levels in women.
Design, Subjects, and Intervention: We studied 36 healthy young (22.4  2.8 yr) and 38 middle-
aged (59.8  5.9 yr) women. All subjects performed 60 min of aerobic exercise three times per week
for 10 wk at about 70% maximal exercise capacity.
Results: After a 10-wk training program, maximal exercise capacity was significantly increased in
both young and middle-aged women, suggesting increased oxidative capacity. Insulin sensitivity
was also improved, as indicated by decreases in plasma insulin levels and homeostasis model
assessment for insulin resistance index. Serum adiponectin and RBP4 concentrations were in-
creased and decreased more in older than younger women, respectively (P  0.01). Concurrently,
circulating transthyretin levels were also decreased in older subjects in response to exercise train-
ing. The older women showed higher correlations between changes in adiponectin or RBP4 levels
and obesity indices or metabolic parameters than the younger group. When subjects showing
increasing adiponectin or decreasing RBP4 levels were classified as responders, there were higher
correlations between these changes in responders than in nonresponders.
Conclusions: We conclude that the mechanism for the insulin-sensitizing effects of exercise could
involve increased adiponectin and reduced RBP4 levels in exercise-trained women. These data
suggest that alterations in circulating RBP4 and adiponectin levels could play an important role in
regulating insulin sensitivity. (J Clin Endocrinol Metab 93: 2263–2268, 2008)
Exercise has been known to increase insulin sensitivity in peo-ple both with and without diabetes (1, 2). According to
several large-scale and prospective studies, higher levels of phys-
ical activity are known to be associated with fewer cardiovas-
cular disease events (3, 4).
Retinol-binding protein-4 (RBP4) is a newly discovered fat-
derived adipokine that specifically binds to retinol (5) and tran-
sthyretin (TTR) (6–8). RBP4 has been reported to provide a link
between obesity and insulin resistance in mice and humans (9,
10). In fact, elevated serum RBP4 levels were associated with the
components of metabolic syndrome in insulin-resistant subjects
(11, 12). Recent studies demonstrated that serum TTR levels
were increased in obese subjects and subjects with impaired glu-
cose tolerance/type 2 diabetes, and its levels were higher in vis-
ceral vs. sc obesity (6). However, some studies reported that
serum RBP4 levels were not elevated in obese elderly women, and
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RBP4 mRNA level was not related to insulin sensitivity (13, 14).
It is therefore unclear whether elevated RBP4 levels contribute to
the pathogenesis of insulin resistance and abnormal glucose me-
tabolism at this time.
Adiponectin has attracted considerable attention recently as
an adipokine that may have critical roles in the development of
atherosclerosis (15). Importantly, low adiponectin levels are a
risk factor for the subsequent development of diabetes and car-
diovascular diseases (16–18). Although several studies have ex-
amined the effects of exercise on circulating adiponectin con-
centrations, the results were inconclusive (19–21). Only one
study demonstrated that the RBP4 level was decreased in re-
sponse to 4 wk of exercise training in a wide age range of subjects
(12).However, regulationofRBP4andTTRbyexercise inyoung
and old women has not been investigated.
In the current study, we investigated whether exercise could
alter circulating RBP4, TTR, and adiponectin levels and whether
these changes would impact whole-body glucose metabolism in
young and middle-aged women. Furthermore, we evaluated
whether the insulin-sensitizing effects of exercise are associated
with the metabolic parameters of insulin resistance.
Subjects and Methods
Subjects
A total of 132 healthy volunteers (mean age 42.1 yr) were recruited
from women visiting a fitness center. We excluded subjects who had
metabolic or cardiovascular diseases. Smokers, ex-smokers, and subjects
who were on any specific diet program were also excluded. Finally, we
recruited 36 healthy young women aged 18–29 yr (younger group) and
38 healthy older women aged 50–71 yr (older group). All subjects par-
ticipated in the study voluntarily, and informed consent was obtained.
The study protocol was approved by Seoul National University Hospital
Ethics Committee.
Exercise program
All subjects underwent a supervised aerobic exercise program that
consisted of three sessions a week for 10 wk, 1 h per session, aiming for
60–80% of their maximal exercise capacity (VO2max). The percentage
of attendance for all subjects was 95%. VO2max was determined by a
stepwise exercise protocol on a bicycle ergometer (Combi, Tokyo, Japan)
with the subjects in the sitting position. The stepping exercise was com-
posed of three levels of load every 4 min, after which the load was in-
creased by 15–20 W/min until volitional exhaustion. Expired gas was
collected in a Douglas bag, and oxygen and carbon dioxide contents were
analyzed with an expired-gas monitor (model 1H2A; San-Ei, Tokyo,
Japan).
Anthropometric and biochemical parameters
Height, weight, waist circumference (WC), and blood pressure were
measured by standard methods. Participants were asked to refrain from
consuming alcohol for 7 d and to fast overnight for 8–14 h before blood
sampling. Plasma was separated immediately by centrifugation
(2000 rpm for 20 min at 4 C), and biochemical assays were performed
immediately. Fasting plasma glucose (FPG) and lipids were measured
enzymatically (Hitachi, Tokyo, Japan). Fasting plasma insulin (FPI) con-
centration was determined by RIA (Linco, St. Charles, MO).
All participants underwent a 2-h, 75-g oral glucose tolerance test
(OGTT) at baseline and after 10 wk of exercise training. Plasma glucose
concentrations were measured before and 30, 60, 90, and 120 min after
the ingestion of a 75-g glucose solution. The total integrated glucose
response was quantified by calculating the area under the curve of glu-
cose (AUCglucose). The homeostasis model assessment (HOMA) was used
for the assessment of pancreatic -cell function (HOMA-) and insulin
resistance (HOMA-IR) (22).
Measurement of RBP4, TTR, and adiponectin
RBP4 level was measured by an ELISA using a polyclonal antihuman
RBP4 antibody. The intraassay precision of the ELISA system in terms of
coefficient of variance was between 4 and 8%, and it was between 5 and
10% between assays. TTR levels were measured by Western blotting
(polyclonal rabbit antihuman TTR IgG; DakoCytomation, Hamburg,
Germany). Absorbance was measured at 595 nm by use of spectropho-
tometer (Microplate Reader; Bio-Rad, Munich, Germany). The interas-
say coefficient of variation was 5–10%. Adiponectin level was measured
using ELISA (Adipogen; Adipogen Inc., Seoul, Korea).
Statistics
All data are presented as the mean  SD. Student’s t test to compare
variables between the groups and paired t tests to analyze changes of
parameters before and after exercise were used. Pearson’s correlation
was used to analyze various parameters and changes in parameters The
Kolmogorov-Smirnov goodness-of-fit test was used to confirm the nor-
mal distribution of factors (Kolmogorov-Smirnov Z  0.686, 1.242,
1.165, and 0.811 in VO2max, adiponectin, RBP4, and HOMA-IR, re-
spectively; all P  0.05). P  0.05 was considered statistically significant
by using SPSS Windows version 11.0 (Chicago, IL).
Results
Baseline characteristics
The body mass index (BMI) and WC of the older group were
greater than that of the younger group. The older group also had
higher baseline levels of blood pressure, FPI, total and low-den-
sity lipoprotein (LDL)-cholesterol, triglyceride, and HOMA-IR
than the younger group but lower levels of high-density lipopro-
tein (HDL)-cholesterol (Table 1). In the OGTT, there were no
subjects with diabetes, but three of younger group and three of
older group were classified into impaired fasting glucose. Two of
the older group were classified with impaired glucose tolerance.
Changes in physiological and biochemical parameters
before and after exercise
In both groups, VO2max, insulin resistance parameters, and
adiponectin concentration increased significantly after exercise
training. However, obesity indices and RBP4 concentration de-
creased significantly in the older group but not in the younger
group (Table 1). We divided subjects into two groups according
to their individual response of adiponectin or RBP4 by exercise:
adiponectin responders, defined when they showed increased
adiponectin, and RBP4 responders, when they showed decreased
RBP4. Finally, adiponectin concentrations were increased in 24
of 36 younger (67%) and 29 of 38 older subjects (76%, adi-
ponectin responders), and RBP4 levels were decreased in 18 of 36
younger (50%) and 29 of 38 older participants (76%, RBP4
responders).
In the comparison by response of adiponectin, indices related
to obesity and insulin resistance including body weight, BMI,
and HOMA-IR were more decreased in responders than nonre-
sponders (P  0.05). Similarly, these factors were more de-
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creased in RBP4 responders than nonresponders. After exercise,
adiponectin concentrations increased by 56.6% in the younger
adiponectin responder group and by 73.0% in the older re-
sponder group. Likewise, RBP4 levels were decreased by 11.4%
in the younger RBP4 responders and by 28.6% in the older re-
sponders (Fig. 1). TTR levels were also decreased significantly in
RBP4 responders of both age groups (Fig. 2). This was in accord
with the pattern of RBP4 levels. Furthermore, there was signif-
icant correlation between changes of RBP4 and those of TTR in
RBP4 responders but not in nonresponders.
Correlations between the changes in adiponectin, RBP4,
and RBP4/adiponectin and the changes in various
parameters
Changes in serum adiponectin levels were correlated with
changes in FPI, HOMA-IR, and VO2max in both groups. In the
older group, it was also correlated with the changes in FPG and
obesity indices, such as body weight, BMI, and WC. Changes of
RBP4 levels were correlated with the changes of surrogate mark-
ers of insulin resistance, WC, triglycerides, and HOMA-IR in
both age groups. Interestingly, the altered RBP4 level showed
significant negative correlation with the change of adiponectin
levels and VO2max only in the older group (r  0.517 and
0.547, P  0.01). When the change () in RBP4/adiponectin
was evaluated, the absolute value of the correlation coefficient
showed an increase in the correlation with the relevant param-
eters in both groups.
Comparison between responders and nonresponders
When dividing subjects into responders and nonresponders
according adiponectin or RBP4 levels after exercise, adi-
ponectin was negatively correlated with FPI, HOMA-IR, and
AUCglucose and positively with VO2max only in older adi-
ponectin responders. For the response of RBP4 to exercise, there
was a positive correlation between WC and RBP4 in both age
responder groups. Furthermore, triglyceride, HOMA-IR,
and AUCglucose were positively correlated with RBP4 only in
older RBP4 responders. There was borderline significance in the
correlations between RBP4 and FPG or FPI.
Regression analysis for independent association with
adiponectin or RBP4
To find independent association with adiponectin or
RBP4, we conducted a regression model for adiponectin as an
independent variable including age, BMI, VO2max, RBP4,
and HOMA-IR as covariates. Finally, VO2max and
HOMA-IR were significantly associated with adiponectin af-
ter adjustment for other variables (P  0.009 and P  0.043,
respectively). Similarly, HOMA-IR was significantly associ-
TABLE 1. Changes in anthropometric and biochemical parameters after 10-wk training program in the younger and older
groups of women
Younger Older
Before exercise After exercise Before exercise After exercise
Age (yr, range) 22.4  2.8 (18–29) 22.4  2.8 (18–29) 59.8  5.9 (50–71)a 59.8  5.9 (50–71)a
Height (cm) 161.7  5.6 161.7  5.6 156.8  3.8a 156.8  3.8a
SBP (mm Hg) 116.5  10.1 116.2  7.6 133.5  11.8a 126.4  8.9c
DBP (mm Hg) 73.6  8.0 73.6  6.0 82.8  9.2a 79.3  5.0c
Body weight (kg) 55.8  6.3 55.1  5.1 61.7  6.2a 59.3  6.0c
BMI (kg/m2) 21.4  2.9 21.2  2.5 25.1  2.9a 24.2  2.7c
WC (cm) 68.4  5.3 67.9  5.0 75.8  7.7a 74.6  7.3c
FPG (mg/dl) 85.0  10.3 81.7  6.9c 88.8  9.6 83.0  6.7c
PG 30 min after OGTT 159.2  19.1 146.1  23.2b 171.4  24.7 155.8  25.6c
PG 60 min after OGTT 144.2  21.0 138.4  26.6 154.5  28.8 141.5  25.2b
PG 90 min after OGTT 129.4  18.4 120.5  21.2b 129.9  27.9 120.6  20.3
PG 120 min after OGTT 113.0  16.3 106.3  19.3 114.4  22.0 104.3  20.1b
AUCglucose 265.9  23.9 249.5  33.6
b 278.7  38.3 255.8  34.0c
FPI (IU/ml) 10.4  3.7 8.8  3.4c 13.7  3.5a 9.9  3.1c
TC (mg/dl) 183.1  26.0 173.1  20.7b 207.1  35.0a 190.1  27.9c
TG (mg/dl) 86.4  25.9 82.3  18.3 125.3  48.4a 113.9  38.9c
HDL-C (mg/dl) 67.0  11.1 70.0  11.3c 59.1  13.8a 66.2  11.4c
LDL-C (mg/dl) 94.5  17.9 87.9  20.3b 116.9  29.6a 102.7  30.3c
HOMA-IR 2.1  0.8 1.8  0.7b 3.0  0.9a 2.0  0.6c
HOMA- 242.2  205.9 215.2  185.6 220.4  98.1 211.0  132.7
AUCglucose 265.9  23.9 249.5  33.6
b 278.7  38.3 255.8  34.0c
VO2max (ml/min) 1812.7  377.4 1865.0  329.9
b 1427.9  320.4a 1643.2  324.1b
Adiponectin (g/ml) 8.1  2.9 10.1  4.6b 11.8  5.4a 16.2  6.0c
RBP4 (g/ml) 40.7  12.2 37.7  9.6 48.1  15.3a 38.0  9.3c
All data are expressed as the mean  SD. Student’s t test was used to compare means of parameters between the young and middle-aged groups, and paired t tests
were used to analyze changes in parameters before and after exercise. C, Cholesterol; DBP, diastolic blood pressure; PG, plasma glucose; SBP, systolic blood pressure;
TC, total cholesterol; TG, total glucose.
a P  0.05 (Student’s t test).
b P  0.05 (paired t tests).
c P  0.01 (paired t tests).
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ated with RBP4 after adjustment for age, BMI, VO2max,
adiponectin, and HOMA-IR (P  0.002).
Discussion
In this study, we found that both adiponectin levels and
VO2max were significantly increased after a 10-wk supervised
exercise program in groups of both younger and older women.
Interestingly, the serum levels of RBP4 were decreased only in the
older group. Furthermore, exercise-induced changes of adi-
ponectin or RBP4 levels were significantly correlated with
changed insulin resistance parameters and obesity indices in both
age groups. These suggest that insulin-sensitizing effects of ex-
ercise are associated with decreased RBP4 and increased adi-
ponectin in both young and old women.
Aerobic conditioning, assessed by VO2max during exercise,
increased only marginally in the younger group who had rela-
tively higher VO2max levels and low insulin concentration and
showed slightly improved insulin sensitivity. However, in the
older group with higher insulin concentration and HOMA-IR,
exercise training increased VO2max more than in the younger
group and was associated with reductions in BMI, WC, and
fasting insulin level and an increase in HDL-cholesterol. Addi-
tionally, in a large cohort study, stronger inverse associations
were observed between physical activity and coronary heart dis-
ease risk among women who were overweight or had elevated
cholesterol levels than those that did not (23). It thus appears that
insulin-sensitizing effects of exercise are more effective in older
women, who are relatively more insulin resistant and obese than
younger women.
The degree of changes in circulating adiponectin and RBP4
levels after exercise was much greater in the older than younger
group. It is conceivable that the basal RBP4 level in old women
but not in young women may be sufficient to be altered by 10 wk
of exercise training. This is further supported by the recent find-
ings that the effects of exercise were clearer in those with high
initial RBP4 levels (12). Along with this, we also found that there
was a higher correlation between the changes in RBP4 concen-
tration and VO2max in the older group, which could be ex-
plained by differences in basal RBP4 levels between the two
groups. Thus, the effect of exercise and its relationship with
insulin resistance seem to be more evident in older subjects who
are less fit and relatively insulin resistant.
Interestingly, there were discrepancies in the effects of exer-
cise on adiponectin and RBP4 levels between responders and
nonresponders in this study, which are defined by their individ-
ual response of adiponectin or RBP4 by exercise.
One possible explanation for this is that the insulin-sensitiz-
ing effect of exercise could be different for each individual. Re-
cent studies demonstrated that the response of RBP4 to 1 month
of exercise training was variable (12), and RBP4 levels were
decreased after exercise mainly in the subjects having higher
RBP4 levels at baseline. Similarly, the older group in our study,
who had higher RBP4 level at baseline, showed a greater decrease
in RBP4 level. However, we can exclude the possibility of dif-








































































FIG. 1. Changing patterns of adiponectin and RBP4 concentrations after 10 wk of aerobic exercise program in younger and older groups of women;
adiponectin concentrations were increased in 24 of 36 younger and 29 of 38 older subjects (adiponectin responders), and RBP4 levels were decreased in
18 of 36 younger and 29 of 38 older participants (RBP4 responders). *, P  0.05.
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fering degrees of exercise because we supervised the intensity and
time of exercise of each individual at every visit. Mean  SD of
percent maximal heart rate during the exercise session was also
almost the same between two groups: 74.6  12.1% in the
younger group and 73.4  8.7% in the older group (P  0.05).
Similarly, the adiponectin levels were elevated in response to
10 wk of exercise training in both young and old women but not
all. This also can be explained by the fact that insulin-sensitizing
effects of exercise on adiponectin could be different for each
individual.
Consistent with a previous report (6), we found that TTR
levels were higher in older women than in younger women. TTR
levels were decreased in response to 10 wk of exercise training in
the RBP4 responders, but there was no significant change in the
nonresponders. Importantly, the changes of RBP4 level were
significantly correlated with those of TTR in RBP4 responders
but not in nonresponders. In serum, RBP4 is bound almost en-
tirely to TTR in a 1:1 molar complex (7). Binding of RBP4 to the
TTR tetramer (56 kDa) is known to stabilize RBP4 in the cir-
culation by prohibiting renal excretion (7, 8). Thus, our results
could be explained by the fact that degree of glomerular filtration
of RBP4-TTR complex may be different or that RBP4-TTR af-
finity is different between responders and nonresponders.
Of note, the younger group had lower
adiponectin levels despite being more insu-
lin sensitive and having lower BMI in this
study. Relatively little is known regarding
the circulating adiponectin levels between
different-aged groups in nondiabetic sub-
jects. A recent study with nondiabetic
women showed adiponectin values were
higher in older compared with younger
women (24). Similarly, higher adiponectin
levels were observed in older postmeno-
pausal women compared with young pre-
menopausal women (25). Taken together,
age, body composition, and menopausal
status may be important factors in regulat-
ing adiponectin concentration in healthy
women.
In conclusion, a 10-wk, moderate-inten-
sity, regular exercise program improved
VO2max and insulin resistance parameters
and modified adiponectin and RBP4 con-
centrations, particularly in older women,
who were more relatively insulin resistant.
These data suggest that exercise, having an
insulin-sensitizing effect, could be a good
therapy to prevent or delay diabetes and
cardiovascular diseases in middle-aged
women through the modification of adi-
ponectin or RBP4 levels.
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